Dermal Fillers Market Size, Share, Growth | Report by 2028

report image

Dermal Fillers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Biodegradable, and Non-Biodegradable); Material (Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate (PMMA), Fat Fillers, and Other Materials); Application (Facial Line Correction Treatment, Lip Enhancement, Face Lift, Scar Treatment, and Others); End user (Multispecialty Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, and Others), and Geography

Publication Month: Aug 2021 | Report Code: TIPRE00002992 | No. of Pages: 195 | Category: Pharmaceuticals | Status: Published

The dermal fillers market is projected to reach US$ 9,421.33 million by 2028 from US$ 4,391.98 million in 2021; it is estimated to grow at a CAGR of 11.5% from 2021 to 2028.

Dermal fillers are anti-aging products that are injected into the skin of patients to add volume. They are injected to make the sagging skin or the skin that has become wrinkled because of age look smooth and plump. They are also called injectable facial fillers, injectable cosmetic fillers, or soft tissue fillers. They are made of hyaluronic acid taken from animals or from the fat of the patient. It takes five minutes to an hour to perform dermal filler procedures. Intradermal fillers can be used in dermatological practices with minimal overhead costs. They address the issues such as facial volume loss and dynamic lines, which are the main indications of facial aging. They provide dermatological practitioners with an array of flexible treatment options for balanced and holistic results. An increase in preference for minimally invasive procedures, growth in population belonging to age group 30–65 and rise in consumer attraction toward beauty and wellness are among the main factors fueling the dermal fillers market growth. However, the high cost of surgeries hampers the market growth.

Lucrative Regions for Dermal Fillers Market

Lucrative Regions for Dermal Fillers Market

Get more information on this report :

Market Insights


Increase in Preference for Minimally Invasive Procedures Drives Dermal Fillers Market Growth

In recent years, the adoption of minimally invasive procedures has increased worldwide. A minimally invasive surgery offers patients several benefits such as smaller incisions, faster recovery times, and reduced pain and scarring. Several minimally invasive dermatological techniques have been developed for facial rejuvenation. Injectable dermal fillers are injected into the upper layers of the dermis to treat superficial fine wrinkles or into the deep dermis or subcutaneous space for facial volume augmentation. Dermal fillers are deposited slowly and steadily. They fill central folds, resulting in a natural, long-lasting outcome. Crease depth, desired effect, and patient's financial situation needs to be considered when deciding the quantity of product to be used. According to statistics provided by the American Society of Plastic Surgeons (ASPS), more than 2.7 million dermal filler procedures were performed in 2019. Further, Allergan stated that the unit sales of dermal filler treatments increased by 17% in.

Age plays a significant role in defining the specific needs of medical esthetic procedures; adults more often request minimally invasive methods. Moreover, people aged 35–55 years prefer minimally invasive esthetic procedures over surgery. Plastic surgeons are becoming more willing to explore them, and minimally invasive cosmetic and esthetic procedures are now an established interdisciplinary topic. The rise of non-surgical technologies and new treatment options has made esthetics more accessible to a broader audience. Patients in their 20s and 30s are helping fuel this trend.

Collectively, the benefits and the accuracy of minimally invasive procedures over traditional surgery are expected to drive the dermal fillers market growth in the coming years. With the ever-increasing popularity of nonsurgical enhancement, the demand for fillers continues to rise.


Product-Based Insights

Based on product, the dermal fillers market is segmented into biodegradable and non-biodegradable. In 2021, the biodegradable segment is expected to hold a larger share of the market, and it is expected to register a higher CAGR in the market during the forecast period. Biodegradable fillers include collagens, hyaluronic acids (hyalurons), hydroxylapatite, poly-l-lactic acid (PLLA), and cadaveric tissue. These products are safe and are approved by the FDA. JUVÉDERM VOLUMA XC offered by Allergan plc., is a sterile, biodegradable, non-pyrogenic, viscoelastic, clear, colorless, and homogenized gel implant. In June 2020, FDA approved JUVÉDERM VOLUMA XC for enhancement of the chin area.

Dermal Fillers Market, by Product – 2021 and 2028

Dermal Fillers Market, by Product – 2021 and 2028

Get more information on this report :


Material-Based Insights

Based on material, the dermal fillers market is segmented into calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polymethylmethacrylate (PMMA), fat, and other materials. The hyaluronic acid segment is expected to hold the largest share of the market in 2021, and the collagen segment is anticipated to register the highest CAGR in the market during the forecast period.

Application-Based Insights

The dermal fillers market, by application, is segmented into facial line correction treatment, lip enhancement, facelift, scar treatment, and others. The facial line correction treatment segment is likely to hold the largest share of the market in 2021, whereas the facelift segment is estimated to register the highest CAGR in the market during the forecast period.

End-User-Based Insights

The dermal fillers market, by end user, is segmented into dermatology clinics, multispecialty hospitals, ambulatory surgical centers, and others. The dermatology clinics segment is estimated to hold the largest market share in 2021. However, the multispecialty hospitals segment is estimated to register the highest CAGR of 12.0% in the market during the forecast period.


Strategic Insights

Report Coverage - Dermal Fillers Market
Report CoverageDetails
Market Size Value inUS$ 4,391.98 Million in 2021
Market Size Value byUS$ 9,421.33 Million by 2028
Growth rateCAGR of 11.5% from 2021-2028
Forecast Period2021-2028
Base Year2021
No. of Pages195
No. of Tables111
No. of Charts & Figures82
Historical data availableYes
Segments coveredProduct ; Material ; Application ; End user , and Geography
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

Various companies operating in the dermal fillers market are adopting strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain brand name, and meet the growing demand from end users.

Dermal Fillers Market – by Product

  • Biodegradable
  • Non-Biodegradable


Dermal Fillers Market – by Material

  • Calcium Hydroxylapatite
  • Hyaluronic Acid
  • Collagen
  • Poly-L-Lactic Acid
  • Polymethylmethacrylate (PMMA)
  • Fat Fillers
  • Other


Dermal Fillers Market – by Application

  • Facial Line Correction Treatment
  • Lip Enhancement
  • Face Lift
  • Scar Treatment
  • Others

Dermal Fillers Market – by End User

  • Dermatology Clinics
  • Multispecialty Hospitals
  • Ambulatory Surgical Centers
  • Others

Dermal Fillers Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
  • South America (SAM)

    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • AbbVie, Inc.            
  • Galderma               
  • Merz Pharma        
  • Suneva Medical    
  • BIOXIS pharmaceuticals    
  • HUADONG MEDICINE CO., LTD       
  • BIOPLUS CO., LTD.               
  • TEOXANE LABORATORIES                
  • BIOHA LABORATORIES      
  • Prollenium Medical Technologies  

Frequently Asked Questions

Dermal fillers are anti-aging products that are injected into the skin of patients to add volume. They are injected to make skin that is sagging or has become wrinkled because of age look smooth and plump. They are also called injectable facial fillers, injectable cosmetic fillers or soft tissue fillers. They are made of hyaluronic acid taken from animals or from the fat of the patient. It takes five minutes to an hour to perform dermal filler procedures. The use of intradermal fillers can be incorporated into dermatological practices with minimal overhead costs. This strategy addresses facial volume loss and dynamic lines, which are the main features of facial aging. Moreover, intradermal fillers provide an array of flexible treatment options for a balanced and holistic result to dermatological practitioners.
Key factors that are driving the growth of this market are preference toward minimally invasive procedures, growth in population between the ages 30 and 65 years and rise in attraction of consumers toward beauty and wellness.
The biodegradable segment dominated the global dermal fillers market and held the largest revenue share of 72.03% in 2021.
The dermatology clinics segment dominated the global dermal fillers market and accounted for the largest revenue share of 49.10% in 2021.
The dermal fillers market majorly consists of the players such AbbVie Inc., Galderma, Merz Pharma, Suneva Medical, BIOXIS pharmaceuticals, Huadong Medicine Co., Ltd, Bioplus Co., Ltd., Teoxane Laboratories, Bioha Laboratories, and Prollenium Medical Technologies among others.
Global dermal fillers market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. The North American region is the largest shareholder, and the Asia Pacific is the fastest growing market for dermal fillers. The market growth in the North American region is expected due to robust adoption of non-surgical procedures coupled with established healthcare infrastructure play vital role for market growth. High disposable income and excellent spending capacity on cosmetic surgeries further influence adoption rate of dermal fillers in the region.

The List of Companies - Dermal Fillers Market

  1. AbbVie, Inc.            
  2. Galderma               
  3. Merz Pharma        
  4. Suneva Medical    
  5. BIOXIS pharmaceuticals    
  6. HUADONG MEDICINE CO., LTD       
  7. BIOPLUS CO., LTD.               
  8. TEOXANE LABORATORIES                
  9. BIOHA LABORATORIES      
  10. Prollenium Medical Technologies
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the dermal fillers market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global dermal fillers market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00002992
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




christmas_festive_offer

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000 $2700
  • $4550 $4095
  • $6550 $5568
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount